Topic: chief medical officer
Belgian immunotherapy developer iTeos Therapeutics has snagged Sanofi’s cancer drug development leader, Joanne Lager, M.D., to be its new CMO.
Fresenius’ new global medical office will head up its work in clinical science and coordinate the company’s global network of clinics.
C4 Therapeutics has poached a new CMO to help carry its targeted protein degraders closer to the clinic through collabs with Biogen, Calico and Roche.
Former Medtronic Diabetes chief medical officer Francine Kaufman has joined continuous glucose monitor developer Senseonics as its new CMO.
After launching its first R&D program, Notable Labs brought on two executives to take charge of its clinical operations and drug development work.
Cerevel Therapeutics is bringing on Otsuka’s Raymond Sanchez, to serve as chief medical officer and take its CNS assets into phase 3.
Decibel Therapeutics brought on a new CMO as it plans proof-of-concept and efficacy studies this year for treating hearing loss side effects.
Gilead’s VP of clinical research, Erin Quirk, is joining the NASH and cancer-focused Terns Pharmaceuticals as its new chief medical officer.
Precision immunodiagnostic firm Navidea Biopharmaceuticals named Michael Rosol, Ph.D., to be its new chief medical officer, effective Dec. 17.
Inflazome has brought on Thomas Jung, M.D., Ph.D., to be its new chief medical officer and lead clinical development of its NLRP3 inhibitors.